1. Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus. (27th December 2021) Authors: Calugareanu, A.; Grolleau, C.; Le Buanec, H.; Chasset, F.; Jachiet, M.; Battistella, M.; Bagot, M.; Jullien, D.; Poutrel, S.; Bouaziz, J.‐D.; Ben Said, B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dramatic improvement of generalized prurigo nodularis with dupilumab. (8th May 2019) Authors: Calugareanu, A.; Jachiet, M.; Lepelletier, C.; De Masson, A.; Rybojad, M.; Bagot, M.; Bouaziz, J.D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 8(2019) Page Start: e303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients. (17th October 2019) Authors: Calugareanu, A.; Jachiet, M.; Tauber, M.; Nosbaum, A.; Aubin, F.; Misery, L.; Droitcourt, C.; Barbarot, S.; Debarbieux, S.; Saussine, A.; Bagot, M.; de Masson, A.; Sénéschal, J.; Staumont‐Sallé, D.; Bouaziz, J.‐D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 2(2020) Page Start: e74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Extensive cutaneous lichen planus triggered by viral vector COVID‐19 vaccination (ChAdOx1 nCoV‐19). (5th January 2022) Authors: Masseran, C.; Calugareanu, A.; Caux, F.; Bohelay, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak. (1st December 2021) Authors: Frumholtz, L.; Bouaziz, J.‐D.; Battistella, M.; Hadjadj, J.; Chocron, R.; Bengoufa, D.; Le Buanec, H.; Barnabei, L.; Meynier, S.; Schwartz, O.; Grzelak, L.; Smith, N.; Charbit, B.; Duffy, D.; Yatim, N.; Calugareanu, A.; Philippe, A.; Guerin, C.L.; Joly, B.; Siguret, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak. (5th October 2021) Authors: Frumholtz, L.; Bouaziz, J.‐D.; Battistella, M.; Hadjadj, J.; Chocron, R.; Bengoufa, D.; Le Buanec, H.; Barnabei, L.; Meynier, S.; Schwartz, O.; Grzelak, L.; Smith, N.; Charbit, B.; Duffy, D.; Yatim, N.; Calugareanu, A.; Philippe, A.; Guerin, C.L.; Joly, B.; Siguret, V. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗